Global Substance Abuse Treatment Market 2017-2021

  • ID: 4312777
  • Report
  • Region: Global
  • 73 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Accord Healthcare
  • Amphastar Pharmaceuticals
  • Cipla
  • INSYS Therapeutics
  • Mylan Laboratories
  • Sanofi Aventis
  • MORE
Substance abuse is defined as an illicit use of alcohol, drugs, or cigarettes. They are potentially addictive in nature, difficult to treat, and have a negative impact on body and overall health. The major factors driving the market is the increase in substance usage and the number of associated deaths. It is also identified as a high economic burden. Substance abuse is one of the primary causes of death globally and a major economic burden. Substance abuse, along with addiction is associated with a variety of chronic diseases.

The report forecasts that the global substance abuse treatment market to grow at a CAGR of 5.15% during the period 2017-2021.

Covered in this report:

The report covers the present scenario and the growth prospects of the global substance abuse treatment market for 2017-2021. To calculate the market size, the report considers the sales from both generic and branded drugs.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
This report, Global Substance Abuse Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion operating in this market.

Key vendors:
  • Alkermes
  • Allergan
  • GSK
  • Pfizer
Other prominent vendors:
  • Accord Healthcare
  • Amphastar Pharmaceuticals
  • Apotex
  • BioCorRx
  • Cipla
  • Glenmark
  • INSYS Therapeutics
  • LFB Group
  • Lupin
  • Mylan Laboratories
  • Opiant Technologies
  • Sanofi Aventis
  • Sanquin
  • Sterinova
  • Sun Pharma
  • Teva Pharmaceutical
Market drivers:
  • Multiple facets of treatment
  • For a full, detailed list, view this report
Market challenges:
  • High cost of treatment
  • For a full, detailed list, view this report
Market trends:
  • Consolidation of rehabilitation centers
  • For a full, detailed list, view this report
Key questions answered in this report:
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Accord Healthcare
  • Amphastar Pharmaceuticals
  • Cipla
  • INSYS Therapeutics
  • Mylan Laboratories
  • Sanofi Aventis
  • MORE
Part 01: Executive Summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction

Part 05: An overview of diseases related to substance abuse

Part 06: Market landscape
  • Market overview
  • Five forces analysis
Part 07: Segmentation by type of abuse
  • Global alcohol abuse treatment market
  • Global nicotine abuse treatment market
  • Global drugs abuse treatment market
Part 08: Geographical segmentation
  • Substance abuse market in Americas
  • Substance abuse market in EMEA
  • Substance abuse market in APAC
Part 09: Decision framework

Part 10: Drivers and challenges
  • Market drivers
  • Market challenges
Part 11: Market trends

Part 12: Vendor landscape
  • Competitive scenario
Part 13: Key vendor analysis
  • Alkermes
  • Allergan
  • GSK
  • Pfizer
  • Other prominent vendors
Part 14: Appendix

List of abbreviations

List of Exhibits
Exhibit 01: Substance abuse: An insight
Exhibit 02: Overview: Global substance abuse market
Exhibit 03: Major diseases associated with substance abuse
Exhibit 04: Global substance abuse treatment market: Snapshot
Exhibit 05: Global substance abuse treatment market 2016-2021 ($ million)
Exhibit 06: Opportunity analysis: Global substance abuse treatment market
Exhibit 07: Five forces analysis
Exhibit 08: Global substance abuse treatment market by type of abuse 2016
Exhibit 09: Global alcohol abuse treatment market 2016-2021 ($ million)
Exhibit 10: Global nicotine abuse treatment market 2016-2021 ($ million)
Exhibit 11: Drugs illicitly used worldwide
Exhibit 12: Global drug abuse treatment market 2016-2021 ($ million)
Exhibit 13: Global substance abuse treatment market by geography 2016 and 2021
Exhibit 14: Global substance abuse treatment market by geography 2016-2021 ($ million)
Exhibit 15: Market scenario in Americas
Exhibit 16: Substance abuse treatment market in Americas 2016-2021 ($ million)
Exhibit 17: Market Scenario in EMEA
Exhibit 18: Substance abuse treatment market in EMEA 2016-2021 ($ million)
Exhibit 19: Market Scenario in APAC
Exhibit 20: Substance abuse treatment market in APAC 2016-2021 ($ million)
Exhibit 21: Various approaches in substance abuse treatment
Exhibit 22: Factors contributing to overall cost of substance abuse treatment
Exhibit 23: Reasons for poor patient compliance
Exhibit 24: Rehabilitation center acquisitions in recent years
Exhibit 25: Competitive structure analysis of global substance abuse treatment market 2016
Exhibit 26: Competitive factors in global substance abuse treatment market
Exhibit 27: Market penetration of vendors in global substance abuse treatment market 2016
Exhibit 28: Strategic success factors of companies in global substance abuse treatment market
Exhibit 29: Alkermes: Strength assessment
Exhibit 30: Alkermes: Strategy assessment
Exhibit 31: Alkermes: Opportunity assessment
Exhibit 32: Allergan: Key highlights
Exhibit 33: Allergan: Strength assessment
Exhibit 34: Allergan: Strategy assessment
Exhibit 35: Allergan: Opportunity assessment
Exhibit 36: GSK: Key highlights
Exhibit 37: GSK: Strength assessment
Exhibit 38: GSK: Strategy assessment
Exhibit 39: GSK: Opportunity assessment
Exhibit 40: Pfizer: Key highlights
Exhibit 41: Pfizer: Strength assessment
Exhibit 42: Pfizer: Strategy assessment
Exhibit 43: Pfizer: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Accord Healthcare
  • Amphastar Pharmaceuticals
  • Cipla
  • INSYS Therapeutics
  • Mylan Laboratories
  • Sanofi Aventis
  • MORE
New Research Report - Global Substance Abuse Treatment Market 2017-2021

Other Prominent Vendors in the market are: Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Mylan Laboratories, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharma, and Teva Pharmaceutical.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is consolidation of rehabilitation centers. In the last decade, rehabilitation centers have increasingly adopted inorganic growth strategies. Acquisition of smaller rehabilitation centers by the major rehab centers across the globe have led to a uniformity in treatment patterns, increased capacity of major rehabilitation centers, and presence across various regions. Many of the smaller mental rehabilitation centers have been acquired and have expanded their functionality to include treatment for substance abuse.”

According to the report, one of the major drivers for this market is multiple facets of treatment. Substance abuse is a complex condition and involves every aspect of an individual's functioning, namely family, work/school, and the community. Therefore, a substance abuse treatment involves multiple components, where some are focused on re-establishing an individual as a productive member of the family and community. This approach is to enable an individual to recognize the benefits of a life without substance abuse.

Further, the report states that one of the major factors hindering the growth of this market is high cost of treatment. The cost of treatment for substance abuse is high owing to multiple phases involved. The total cost involves expenses associated with rehabilitation centers and facilities; therapeutics cost’ and cost associated with the physicians, psychologists, councillors, nutritionists, and many other professionals providing secondary therapies. These secondary therapies include patient counselling, health services, and detoxification services, among others.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Alkermes
  • Allergan
  • GSK
  • Pfizer
  • Accord Healthcare
  • Amphastar Pharmaceuticals
  • Apotex
  • BioCorRx
  • Cipla
  • Glenmark
  • INSYS Therapeutics
  • LFB Group
  • Lupin
  • Mylan Laboratories
  • Opiant Technologies
  • Sanofi Aventis
  • Sanquin
  • Sterinova
  • Sun Pharma
  • Teva Pharmaceutical
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll